Close
Back to mobile site

Pfizer (PFE) Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV

December 14, 2018 10:29 AM EST Send to a Friend
Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login